Improvement of cardiovascular risk profile in an elderly population of low social level: The ICON (Improving Cardiovascular risk profile in Older Neapolitans) study

Journal of Human Hypertension

Volumn 21, Issue 1, 2007, Pages 76-85

  Marotta, T ^a   Viola, S ^b   Ferrara, F ^b   Ferrara, L A ^b  

^a Azienda Sanitaria Locale Napoli 1   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT; DIGITALIS; GLYCERYL TRINITRATE;

ADULT; AGED; AGING; ARTICLE; AWARENESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DOCTOR PATIENT RELATION; DYSLIPIDEMIA; EDUCATION; EMPLOYMENT; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OBESITY; OUTPATIENT CARE; PATIENT SATISFACTION; PRACTICE GUIDELINE; PREVALENCE; PRIMARY SCHOOL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK MANAGEMENT; SOCIOECONOMICS;

AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; PATIENT EDUCATION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 33845547581     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002098     Document Type: Article

References (53)

1. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-486.
2. Shah S, Cook DG. Inequalities in the treatment and control of hypertension: Age, social isolation and lifestyle are more important than economic circumstances. J Hypertens 2001; 19: 1333-1340.
3. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005; 165: 1147-1152.
4. Boden-Albala B, Litwak E, Elkind MS, Rundek T, Sacco RL. Social isolation and outcomes post stroke. Neurology 2005; 64: 1888-1892.
5. Bachmann MO, Eachus J, Hopper CD, Davey Smith G, Propper C, Pearson NJ et al. Socio-economic inequalities in diabetes complications, control, attitudes and health service use: A cross-sectional study. Diabetic Medicine 2003; 20: 921-929.
6. Mayer Jr O, Simon J, Heidrich J, Cokkinos DV, De Bacquer D. Educational level and risk profile in the EUROASPIRE II substudy. J Epidemiol Community Health 2004; 58: 47-52.
7. Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ et al. Socioeconomic status variables predict cardiovascular disease risk factors and prospective mortality risk among women with chest pain. The Wise Study. Behav Modif 2003; 27: 54-67.
8. Neuwirth ZE. Physician empathy - should we care? Lancet 1997; 350: 606.
9. Rosengren A, Hawken S, Ôunpuu S, Sliwa K, Zubaid M, Almahmeed WA et al., for the INTERHEART investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls fron 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 953-962.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al., and the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
11. Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: A meta-analytic review. J Consult Clin Psychol 2000; 68: 438-450.
12. European Society of Hypertension - European Society of Cardiology Guidelines Committee. 2003 guidelines for the management of arterial hypertension. J Hypertension 2003; 21: 1011-1053.
13. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
14. Executive summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
15. Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
16. SPSS for Windows. http://www.spss.com/spss.
17. Vannoni F, Spadea T, Frasca G, Tumino R, Demaria M, Sacerdote C et al. Association between social class and food consumption in the Italian EPIC population. Tumori 2003; 89: 669-678.
18. Seccareccia F, Zuccaro P, Farchi G, Giampaoli S, Vanuzzo D. e Gruppo di Ricerca dell'Osservatorio Epidemiologico Cardiovascolare. Fumo e prevenzione delle malattie cardiovascolari in Italia. Ital Heart J Suppl 2000; 1: 910-918.
19. Celentano E, Palmieri L, Galasso R, Poce A, Panico S, Giampaoli S. Cardiovascular risk factors and social classes: A comparison between adult female populations in rural and urban areas. G Ital Cardiol 1999; 29: 692-697.
20. Cirera L, Tormo MJ, Chirlaque MD, Navarro C. Cardiovascular risk factors and educational attainment in Southern Spain: A study of a random sample of 3091 adults. Eur J Epidemiol 1998; 14: 755-763.
21. Giampaoli S, Palmieri L, Dima F, Pilotto L Vescio MF, Vanuzzo D, a nome del Gruppo di Ricerca dell'Osservatorio Epidemiologico Cardiovascolare. Aspetti socio-economici e fattori di rischio cardiovascolare: l'esperienza dell'Osservatorio Epidemiologico Cardiovascolare. Ital Heart J Suppl 2001; 2: 294-302.
22. Appel LJ. Lifestyle modification as a means to prevent and treat high blood pressure. J Am Soc Nephrol 2003; 14: S99-S102.
23. de Koning JS, Klazinga N, Koudstaal PJ, Prins A, Borsboom GJ, Peeters A et al. Deprivation and systematic stroke prevention in general practice: an audit among general practitioners in the Rotterdam region, The Netherlands. Eur J Public Health 2003; 13: 340-346.
24. Mancia G, Volpe R, Boros S, Ilardi M, Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens 2004; 22: 51-57.
25. de Gaudemaris R, Lang T, Chatellier G, Larabi L, Lauwers-Cancés V, Maître A et al. Socioeconomic inequalities in hypertension prevalence and care. The IHPAF study. Hypertension 2002; 39: 1119-1125.
26. Pekkanen J, Tuomilehto J, Uutela A, Vartiainen E, Nissinen A. Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ 1995; 311: 589-593.
27. Diez-Roux AV, Northridge ME, Morabia A, Bassett MT, Shea S. Prevalence and social correlates of cardiovascular disease risk factors in Harlem. Am J Public Health 1999; 89: 302-307.
28. Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, Agardh CD. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab 2003; 5: 106-112.
29. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E et al. Metabolic syndrome and target organ damage in untreated essential hypertension. J Hypertens 2004; 22: 1991-1998.
30. Mulè G, Nardi F, Cottone S, Cusimano P, Volpe V, Piazza G et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257: 503-513.
31. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
32. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K. Risk factors for the metabolic syndrome. The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004; 27: 2707-2715.
33. Wamala SP, Lynch J, Horsten M, Mittleman MA, Schenck-Gustaffson K, Orth-Gomér K. Education and the metabolic syndrome in women. Diabetes Care 1999; 22: 1999-2003.
34. Dallongeville J, Cottel D, Ferrières J, Arveiler D, Bingham A, Ruidavets JB et al. Household income is associated with the risk of metabolic syndrome in a sex-specific manner. Diabetes Care 2005; 28: 409-415.
35. Alegría E, Cordero A, Laclaustra M, Grima A, León M, Casanovas JA et al. Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry. Rev Esp Cardiol 2005; 58: 797-806.
36. Stelmach W, Kaczmarczyk-Chalas K, Bielecki W, Drygas W. How education, income, control over life and life style contribute to risk factors for cardiovascular disease among adults in a post-communist country. Public Health 2005; 119: 498-508.
37. Kim MH, Kim MK, Choi BY, Shin YJ. Educational disparities in the metabolic syndrome in a rapidly changing society. The case of South Korea. Int J Epidemiol 2005; 34: 1266-1273.
38. World Health Organization. World Health Report 2005 - make every mother and child count. Geneva 2005. http://www.who.int/whr/2005/en (accessed on 11 September 2005).
39. Swales JD. Current status of hypertensive disease treatment: Results from the Evaluation and Interventions for Systolic Blood pressure Elevation: Regional and Global (EISBERG) project. J Hypertens Suppl 1999; 17: S15-S19.
40. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: Current outcomes and control in the community. JAMA 2005; 294: 466-472.
41. Mancia G, Ambrosioni E, Agabiti-Rosei E, Leonetti G, Trimarco B, Volpe M, ForLife study group. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: Results of the ForLife study. J Hypertens 2005; 23: 1575-1581.
42. Mancia G, Pessina AC, Trimarco B, Grassi G; SILVIA (Studio Italiano Longitudinale sulla Valutazione della Ipertensione Arteriosa nel 2000) Study Group. Blood pressure control according to the new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens 2004; 22: 2387-2396.
43. Abraha I, Montedori A, Stracci F, Rossi M, Romagnoli C. Statin compliance in the Umbrian population. Eur J Clin Pharmacol 2003; 59: 659-661.
44. Cuspidi C, Lonati L, Sampieri L, Macca G, Valagussa L, Zaro T et al. Blood pressure control in a hypertension hospital clinic. J Hypertens 1999; 17: 835-841.
45. Bansal N, Tendler BE, White WB, Mansoor GA. Blood pressure control in the hypertension clinic. Am J Hypertens 2003; 16: 878-880.
46. Ohta Y, Tsuchihashi T, Fujii K, Matsumura K, Ohya Y, Uezono K et al. Improvement of blood pressure control in a hypertension clinic: A 10-year follow-up study. J Hum Hypertens 2004; 18: 273-278.
47. Lied TR, Kazandjan VA. A Hawthorne strategy: Implications for performance measurement and improvement. Clin Perform Qual Health Care 1998; 6: 201-204.
48. Wood D, DeBacker G, Faergeman O, Graham I, Mancia G, Pyöralä K, For the Task Force. Prevention of coronary heart disease in clinical practice: Recommendations of the second joint Task Force of European and other Societies on coronary prevention. Atherosclerosis 1998; 140: 199-270.
49. Hojat M, Gonnella JS, Nasca T, Mangione S, Vergare M, Magee M. Physician empathy: Definition, components, measurement, and relationship to gender and specialty. Am J Psychiatry 2002; 159: 1563-1569.
50. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: A systematic review. Lancet 2001; 357: 757-762.
51. Medical Professionalism Project. Medical professionalism in the new millennium: A physicians' charter. Lancet 2002; 359: 520-522.
52. Royal College of Physicians. Doctors in Society: Medical Professionalism in a Changing World. RCP: London, 2005.
53. Shang A, Huwiler-Müntener K, Nartey L, Jüni P, Dörig S, Sterne JAC et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366: 726-732.